Clinical Professor
University of Michigan, College of Pharmacy
Ann Arbor, MI, United States
Dr. Jason Pogue is a clinical professor at The University of Michigan College of Pharmacy. He also serves as an infectious diseases clinical pharmacist at Michigan Medicine in Ann Arbor, MI. Dr. Pogue received a bachelor degree in Chemistry from Gannon University in Erie, Pennsylvania, before obtaining his doctor of pharmacy degree from the University of Pittsburgh. He then completed a PGY-1 residency at the University of Pittsburgh Medical Center, after which he obtained his PGY-2 ID training at the University of Michigan Health Systems. After residency training Dr. Pogue spent a decade as an infectious diseases clinical pharmacist at Sinai-Grace Hospital in Detroit, MI where he co-chaired the antimicrobial stewardship program and led many stewardship initiatives throughout the Detroit Medical Center. His research interests focus on epidemiology and treatment of multi-drug resistant Gram-negative organisms and antimicrobial stewardship and he has co-authored over 140 peer reviewed articles and multiple book chapters in these areas. Dr. Pogue currently serves as the co-lead investigator for the PRECEDENT network, a consortium of over 40 hospitals in the United States focused on performing real-world, comparative effectiveness syudies of novel antimicrobial agents for the treatment of resistant Gram-negative pathogens (https://www.precedentnetwork.com). Dr. Pogue is a past president of The Society of Infectious Diseases Pharmacists (SIDP) and currently serves as the Chairman of the Executive Committee for the United States Committee on Antimicrobial Susceptibility Testing (USCAST) an organization dedicated to modernizing antimicrobial susceptibility breakpoints.
Disclosure(s): Entasis: Advisor/Consultant; GSK: Advisor/Consultant; Melinta: Advisor/Consultant, Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support; Venatorx: Advisor/Consultant
Friday, October 18, 2024
10:42 AM – 10:54 AM US PT